Immunotherapy has proven successful to reduce the cancer mortality in metastatic melanoma1, although the 5-year survival rates of patients with advanced melanoma are usually still <30% (ref. 2). It highlights the importance to study the role of earlier steps in immune responses to tumor colonization.

A recent finding is the identification of a single-nucleotide polymorphism in the Ncf1 gene to be a genetic basis for autoimmunity3,4,5. The Ncf1 gene encodes neutrophil cytosolic factor 1 (NCF1, earlier denoted p47PHOX), a cytosolic component of the NADPH oxidase 2 (NOX2) complex6. NCF1 is required for the NOX2 complex to trigger oxidative burst, i.e., an induced production of reactive oxygen species (ROS)7, and identified Ncf1 mutations result in a decrease of ROS production8,9. NCF1 is highly expressed in neutrophils and CD68-positive cells10. CD68-expressing cells, predominantly macrophages, are a critical mediator regarding autoimmune disease susceptibility, exhibiting the properties of both innate and adaptive immune responses. The downstream effect of the Ncf1 mutation includes regulation of T cells in autoimmune arthritis10,11 and encephalomyelitis12, exaggerated type I interferon signaling in lupus autoimmunity13,14, innate interleukin 17 (IL-17) induction in psoriatic diseases15,16,17, and impairment of the capacity to form neutrophil extracellular traps in patients with gout18 and gallstones19.

The induced immune responses by Ncf1 mutations may on the other hand prevent cancer. It has been shown that myeloid cells producing ROS could suppress the cytotoxic T-cell response to tumor cells20. We and others have found that impaired NCF1 and NOX2 function are protective against the melanoma development21,22. We have now chosen the shared melanoma model B16F10 cell line, supplied by ATCC, to probe the mechanisms of cell-specific Ncf1 mutations in tumor colonization.

In this study, we transferred the Ncf1 mutation (Ncf1*/*) into mouse strains with different major histocompatibility complex (MHC) haplotypes on the C57BL genetic backgrounds. Using the MHC congenic mice in the mouse melanoma model, we observed a reduced number of lung colonies in Ncf1 mutant mice. We excluded a critical role of T cells, B cells, and macrophages, but found that neutrophils were the most important cell for the Ncf1 mutation-mediated protection. MRP8-restricted expression of a functional Ncf1 restored the release of IL-1β from neutrophils and the susceptivity to tumor colonization. Thus, this study provides insights into the role of NOX2-derived ROS in driving tumor colonization through a neutrophil and IL-1β-dependent pathway.


Protection despite the deficiencies of T and B cells

To study the role of redox regulation of tumor colonization, we introgressed the Ncf1 mutation in mice with the MHC b, q, and r haplotypes on the shared C57BL genome background. Lung tumor foci were counted at day 10 after intravenous inoculation of B16F10 cells. We found that Ncf1 mutant mice (Ncf1*/*) were protected from metastatic colonization, regardless of the MHC haplotype (Fig. 1a), arguing against redox control of allogenic-mediated rejection.

Fig. 1: Ncf1 mutation reduces lung colonies of B16F10 cells.
figure 1

The lungs were harvested from mice at day 10 after intravenous injection of B16F10 cells. a The number of tumor colonies in Ncf1 mutant mice (Ncf1*/*) and wild-type controls (Ncf1+/+) of B6N.Ncf1*/* (n = 7) versus B6N.Ncf1+/+ (n = 5), B6Q.Ncf1*/* (n = 5) versus B6Q.Ncf1+/+ (n = 6), and B6R.Ncf1*/* (n = 5) versus B6R.Ncf1+/+ (n = 5). b The number of tumor colonies in wild-type mice (Ncf1+/+.MN−/−, n = 7), MN mice (Ncf1*/*.MN+/+, n = 7), and Ncf1 mutant mice (Ncf1*/*.MN−/−, n = 7). c A representative flow cytometry plot graph shows the gating of CD45+CD11b+F4/80+ cells (macrophages), and d, ROS production by DHR staining in flow cytometry, after lung cells were incubated ex vivo with PMA and DMSO as the control (six mice per group). e The number of tumor colonies in mice of Ncf1*/*.TCRδ−/− (n = 9) versus Ncf1*/*.TCRδ+/+ (n = 6), Ncf1*/*.TCRβ−/− (n = 4) versus Ncf1*/*.TCRβ+/+ (n = 6), and Ncf1*/* (n = 6) versus Ncf1*/*.μMT (n = 4), compared with that in wild-type mice (n = 6). All results are shown as mean ± SEM. Mann–Whitney U test, *p < 0.05, **p < 0.01, and ***p < 0.001.

To further study the cell-type-specific effect of ROS deficiency, we investigated the role of macrophages and monocytes. We used the transgenic MN mice (Ncf1*/*.MN+/+) expressing NCF1 restricted to CD68-positive cells, and a fluorophore dihydrorhodamine 123 (DHR) to measure the ROS production of individual cells upon stimulation with phorbol 12-myristate 13-acetate (PMA). Our results show that the lung tumor foci were not changed in MN mice versus Ncf1 mutant mice (Fig. 1b), although ROS production was restored in macrophages/monocytes (Fig. 1c, d). Furthermore, Ncf1-mutated mice with deficiencies of T-cell receptor (TCR)-beta (Ncf1*/*.TCRβ−/−), TCR-delta (Ncf1*/*.TCRδ−/−), and B cell (Ncf1*/*.μMT) showed comparable levels of tumor colonies, similar to their littermate controls (Fig. 1d). These observations does not exclude an influence, but exclude a critically redox regulatory role of macrophages/monocytes, T and B cells in supporting lung colonization.

Susceptibility to colonization restored by neutrophils

In the continuous search for the critical cells in mediating the Ncf1 regulatory role, we investigated the role of neutrophils. We designed a conditional knock-in mouse model expressing a functional copy of the Ncf1 gene in neutrophils by a Cre under control of the MRP8 promoter on Ncf1-deficient background (Ncf1TN3/*.Mrp8Cre/+). In prior to experiments, we validated the conditional expression of NCF1 in bone marrow neutrophils sorted from naive Ncf1TN3/*.Mrp8Cre/+ mice (Fig. S1a). We observed oxidative burst of blood neutrophils in the naive Ncf1TN3/*.Mrp8Cre/+ (Fig. 2a), whereas the ROS production of blood monocytes was not restored (Fig. S1b). We performed the tumor colonization assay with the knock-in mice. A higher number of tumor colonies were found in the lungs at day 10 of Ncf1TN3/*.Mrp8Cre/+ mice (Fig. 2b).

Fig. 2: Tumor colonies are increased by neutrophil-restricted expression of functional Ncf1.
figure 2

a ROS production by neutrophil as assessed by flow cytometry with DHR, after blood cells were incubated ex vivo with PMA and DMSO as the control. The naive mice were used, including wild-type mice (Ncf1+/+, n = 4), Ncf1 mutant mice (Ncf1*/*, n = 5), transgenic mice (Ncf1TN3/*.Mrp8Cre/+, n = 5), and their littermates (Ncf1TN3/*.Mrp8+/+, n = 4). b The number of tumor colonies on lungs per mouse was counted in transgenic mice and Ncf1 mutant mice. c Representative flow cytometry plot graphs of CD45, CD11b, Ly6G, and Ly6C in lung cells. d The mean fluorescence intensity (MFI) of pro-IL-1β staining as the level of pro-IL-1β in the lung neutrophil was assessed by flow cytometry. In b, c, and d, the lungs were harvested from transgenic mice (Ncf1TN3/*.Mrp8Cre/+, n = 6) and Ncf1 mutant mice (Ncf1TN3/*.Mrp8+/+, n = 7) to be analyzed at day 10 after intravenous injection of B16F10 cells. All results are shown as mean ± SEM. Mann–Whitney U test, *p < 0.05, **p < 0.01.

Previously, we and others have found a role of ROS in the regulation of IL-1β expression12,23. In this study, we show that ROS-sufficient neutrophils express an enhanced IL-1β in conditional knock-in mice (Fig. 2c, d). Consistently, expression of IL-1β was enhanced in lung neutrophils from wild-type mice (Ncf1+/+; Fig. S1c), as well as CD54 known as a molecular bridge24 at the interaction between tumor cells and neutrophils (Fig. S1d). These results suggest that neutrophils play a critical role to promote lung colonization by ROS through activating IL-1β secretion.

Downstream mediators through IL-1β signals

We next studied the effects of IL-1β in the tumor colonization model. For this purpose, we collected bronchoalveolar lavage fluid (BALF) at day 10 after intravenous injection of B16F10 cells. The analysis of flow cytometry data shows a decreased level of IL-1β in BALF from Ncf1 mutant mice (Ncf1*/*; Fig. 3a). In addition, we observed the cytokine expressions of TNFα, IFN-γ, IL-4, and IL-1α in the same BALF, but there was no significant difference between Ncf1 mutant group and wild-type controls (Fig. S1e).

Fig. 3: Administration of rmIL-1β increases lung colonization in Ncf1 mutant mice.
figure 3

The bronchoalveolar lavage (BAL) fluids and lungs were harvested from wild-type mice (Ncf1+/+) and Ncf1 mutant mice (Ncf1*/*) at day 10 after intravenous injection of B16F10 cells. a The level of IL-1β in the BAL fluid was assessed by flow cytometry. b The number of tumor colonies in lungs per mouse was counted in wild-type mice with injections of rmIL-1β (n = 5) versus PBS (n = 11), and Ncf1 mutant mice with injections of rmIL-1β (n = 8) versus PBS (n = 11). c ROS production by neutrophils in the lungs was assessed by flow cytometry with DHR, after these cells were incubated ex vivo with PMA and DMSO as the control. The lung tissues were collected from wild-type mice with injections of rmIL-1β (n = 5) versus PBS (n = 5), and NCF1-deficient mice with injections of rmIL-1β (n = 5) versus PBS (n = 5) at day 10 post-injection of B16F10 cells. All results are shown as mean ± SEM. Mann–Whitney U test, *p < 0.05, **p < 0.01 and ***p < 0.001.

To address a possible functional role, we treated the mice with recombinant mouse IL-1β (rmIL-1β) half an hour prior to the inoculation of B16F10 cells. We show that IL-1β treatment enhanced lung colonization, independently of the Ncf1 polymorphism (Fig. 3b). The oxidative burst capability of lung neutrophils was also not affected by injection of rmIL-1β (Fig. 3c). Interestingly, we observed a reduced number of mature natural killer (NK) cells (CD45+CD3NK1.1+) in lungs (Fig. S2a), i.e., CD27KLRG1+ NK cells in an Ncf1-dependent manner, after a single injection of rmIL-1β in vivo (Fig. S2b, c). Mature NK cells can have a major role in controlling B16F10 lung colonization25, and then we studied the effect of NK cells by injecting NK1.1 antibody26,27,28. As expected, depletion of NK cells leads to an increase of the lung colonization of B16F10 tumor cells (Fig. S2d). However, the Ncf1 mutation-mediated protection was consistent regardless of NK cell depletion (Fig. S2d). These results suggest that IL-1β promote tumor colonization as a downstream effect of ROS. NK cells may play a role in IL-1β signaling, but not critically in regulating the Ncf1 effect.

Enhanced colonization after neutrophil depletion

Our data indicate that neutrophils play a critical role in ROS-mediated tumor colonization. To deplete neutrophils, we injected anti-Ly6G antibodies (clone 1A8) in wild-type mice, MN mice, and Ncf1 mutant mice, and evaluated neutrophil infiltration at day 10 in the lungs of B16F10-exposed mice (Fig. 4a). The numbers of lung neutrophils (CD45+CD11b+Gr1+Ly6Cmid) were reduced in all strains (Fig. 4b, c), while an increased number of monocytes (CD45+CD11b+Gr1midLy6Chi) was observed in wild-type mice (Fig. S3a). Contrary to the previous results that neutrophils depletion with anti-GR1 antibody (clone RB6-8C5) reduced the tumor growth29,30, and that 1A8 antibody treatment had no impact on lung colonization in C57BL/6 mice31, our data shows that 1A8 antibodies enhanced lung colonization in Ncf1 wild-type mice on the C57BL/6 genetic background. Importantly however, this phenomenon was Ncf1 dependent as it was not seen in either Ncf1 mutant or MN mice (Fig. 4d). A possible contribution to an increase of tumor colonies could be the expression of the receptor for advanced glycation endproducts (RAGE) on monocytes from wild-type mice (Fig. S3b). RAGE is known to be a receptor of MRP8 at the interaction between tumor cells and myeloid cells24,32. To determine the role of RAGE in oxidative regulation, we treated mice with the RAGE blocker FPS-ZM1 (ref. 33). Interesting, FPS-ZM1 reduced lung colonization in wild-type mice to the same low level as in Ncf1 mutant mice (Fig. S3c, d). These results suggest that MRP8-RAGE signaling could activate monocytes to support tumor colonization after the ROS-sufficient neutrophil depletion.

Fig. 4: Treatment with anti-Ly6G antibodies increases lung colonization for mice with NCF1-expressing neutrophils.
figure 4

The studies used wild-type mice (Ncf1+/+.MN−/−), MN mice (Ncf1*/*.MN+/+), and Ncf1 mutant mice (Ncf1*/*.MN–/−). B16F10 cells that were injected into mice at day 0, and the number of tumor colonies in lungs per mouse was counted at day 10 post-injection of B16F10 cells. a Administrations of anti-Ly6G antibodies were applied at days −1, 2, 5, and 8 post-injection of B16F10 cells. The study includes the wild-type mice with injections of anti-Ly6G antibody (clone:1A8; n = 7) versus isotype control (clone:2A3; n = 7), MN mice with injections of 1A8 (n = 6) versus 2A3 (n = 6), and Ncf1 mutant mice with injections of 1A8 (n = 6) versus 2A3 (n = 6). b Representative flow cytometry plot graphs of CD11b, Gr1, and Ly6C in lung cells. c The number of neutrophils in lungs per mouse was counted. d The number of tumor colonies in lungs per mouse was counted in mice with injections of anti-Ly6G antibodies versus isotype control. All results are shown as mean ± SEM. Mann–Whitney U test, *p < 0.05, **p < 0.01.


A natural mutation in the Ncf1 gene leading to an impaired production of ROS by the NOX2 complex protects against B16 melanoma tumor colonization of the lungs. The protection was reversed by conditional expression of a functional Ncf1 gene in neutrophils. Subsequently, the neutrophil-derived IL-1β was demonstrated to promote lung colonization of B16F10 cells.

ROS could be produced by both tumor cells and infiltrating immune cells during metastatic colonization, and the location of ROS may determine oxidative effect on tumor growth. A recent study provided evidence that metabolic ROS support the metastasis process of tumor cells in clusters, compared with single cells34. The cluster could also be formatted between tumor cells and neutrophils. A phenomenon was reported that neutrophil–tumor clusters exhibit the capability to expand the metastatic potential of B16F10 cells24, but the role of ROS was not addressed. Normally, the NCF1–NOX2 complex is efficiently activated, dominating to the production of ROS in neutrophils. In this study, we validated with mouse models for the first time that a copy of functional Ncf1 gene expression in neutrophils driven by the MRP8 promoter was enough to increase the level of lung metastatic foci.

ROS may shape the direct interaction between the injected tumor cells and infiltrating neutrophils. B16F10 cells lack detectable expression of ICAM-1 (ref. 35) and IL-1β36, but these two proteins could play pro-tumorigenic roles24,37,38. ICAM-1 expressed on neutrophils is important for neutrophil–tumor cell cluster formation24. ICAM-1 is absent or expressed at very low levels on circulating neutrophils, but could be induced by selected triggers39. In this study, we show that tumor-associated neutrophils expressed ICAM-1 and IL-1β in the lungs. Ncf1 mutant mice exhibit a few number of ICAM-1-positive neutrophils. Importantly, the level of IL-1β expression was upregulated in the tissue neutrophils by conditional knock-in of a functional Ncf1 gene. A single injection of IL-1β compensated for the effect of ROS deficiency on tumor colonization, increasing tumor colonies to a high level. Recently, it has been reported that deficiency of the developmental endothelial locus–1 in the host may promote neutrophil accumulation in the lung metastatic niche, where neutrophil-released ROS mediates a direct interaction with B16F10 cells40.

Another direct interaction between neutrophils and tumor cells could involve the RAGE receptor on B16F10 cells, of which the MRP8 is a potent ligand41. The myeloid cells, including neutrophils, monocytes, and the interstitial macrophage-like phenotype, might express both the NCF1–NOX2 complex and MRP8, referred to the formation of the pre-metastatic microenvironment that is required for blood tumor cells to engraft at the lung niche42. Thus, it is difficult to distinguish the neutrophils from monocytes/macrophages on the immunoregulation. Expression of a functional Ncf1 gene in CD68-positive cells can reduce the pathogenicity of T cells in experimental autoimmune arthritis models10. In this study, we show that the Ncf1 mutation protected from tumor colonization, irrespective of the CD68-expressing cell status. What is more, depletion of ROS-sufficient neutrophils with 1A8 antibodies was likely to trigger the ROS-dependent RAGE expression on Ly6C monocytes.

In addition, NK cells could play a prominent role in the protection against lung colonization. Aydin and colleagues studied the role of NK cells in Nox2-knockout mouse models by anti-NK1.1 antibody injection, finding an NK cell-associated anti-metastatic effect of histamine dihydrochloride in Nox2 wild-type mice, but not in Nox2-knockout mice26,27. Li and colleagues investigated the role of the cytokine G-CSF in tumor models on use of both NOD-scid and NSG mice, suggesting a neutrophil-mediated role of NK cells in lung metastasis28. It is known that innate lymphoid cells are also deficient in NSG mice43. To study the importance of neutrophils, Boivin and colleagues found that neutrophils could even expand in blood and spleens after anti-Ly6G treatments at a low dose29. Clearly, NK cells play an important role in the protection of lung colonization, but it remains unknown whether NK cells are involved with the protective effect of the NCF1–NOX2 complex. It should be pointed out that the small compound histamine dihydrochloride might not specifically affect NK cells, and there is also genetic difference between the knockout mouse strains and naturally mutant strains. For an example, both Nox2-knockout mice and Ncf1-knockout mice have been reported to be protected from experimental autoimmune encephalomyelitis44, but the Ncf1 mutant mice exhibited an enhanced autoimmune encephalomyelitis12,45. Therefore, we further studied the role of NK cells in the Ncf1 mutant mice using anti-NK1.1 antibody26. However, we found that NK cell depletion, by anti-NK1.1 treatments, enhanced tumor metastasis independent of the Ncf1 mutation.

In summary, we used naturally mutant mouse models of the Ncf1 gene to screen the cell-type-specific effect of the NOX2 complex deficiency, and then found out that only Ncf1 expression in neutrophils can restore the susceptibility to tumor colonization. We found that the Ncf1 competent neutrophils, exhibiting the capability of functional ROS induction and IL-1β signaling, can promote lung colonization. As the Ncf1 expression is polymorphic in both humans and experimental animals, and since redox regulation is a key pathophysiologic process, this observation could be of key importance not only to understand the basis of tumor metastasis, but also to improve cancer treatment.



Founders of B6N (C57BL/6N) and B10RIII mice are originally from the JAX Lab (Bar Harbor, Maine), and the MHC congenic B6Q (C57/B6N.Q/rhd) and B10Q (C57/B10N.Q/rhd) mice have been fully backcrossed and maintained by the Holmdahl laboratory as inbred lines (rhd). The congenic mice of B6R strain have been established by an initial cross of a B10RIII mouse with B6N mice, followed by at least eight times of repeated backcrossing to B6N mice. A mutation in the Ncf1 gene (m1j) in the B6N mice, designated as B6N.Ncf1m1j/m1j (B6N.Ncf1*/*) impairs the expression of the Ncf1 gene, thereby totally blocking the function of the NOX2 complex. The derived Ncf1 mutant mouse strains include B6Q.Ncf1*/*, B10Q.Ncf1*/*, and B6R.Ncf1*/*. The transgenic MN mice with the human CD68 promoter exhibit macrophage/monocytes-restricted NCF1 expression (B10Q.Ncf1*/*.MN+/+)10. The MRP8-Cre transgenic mice (stock no: 021614) were used to cross with the targeted Ncf1 mutant mice (B6Q.Ncf1TN3/TN3), producing the mice with a conditional knock-in of a functional Ncf1 gene in neutrophils, i.e., B6Q.Ncf1TN3/*.Mrp8Cre/+. TCRβ-deficient mice (stock no: 002118, B6.129P2-Tcrbtm1Mom/J), TCRδ-deficient mice (stock no: 002120, B6.129P2-Tcrd tm1Mom/J), B-cell-deficient mice (stock no: 002288, B6.129S2-Ighm tm1Cgn/J) were obtained from The Jackson Laboratory and were fully backcrossed to our B10Q.Ncf1*/* mice to get B10Q.Ncf1*/*.TCRβ−/− mice, B10Q.Ncf1*/*.TCRδ−/− mice, B10Q.Ncf1*/*.μMT mice, respectively. The primers for TCRβ genotyping are as following: 5′-GCT ACT TCC ATT TGT CAC GTC C-3′ (mutant forward), 5′-CCC CAC CCA GTA TAG GAC AG-3′ (wild-type forward), 5′-CCT CAA CCC AGA ATG ATC TTG-3′ (common). The primers for TCRδ genotyping are as following: 5′-CTT GGG TGG AGA GGC TAT TC-3′ (mutant forward), 5′-AGG TGA GAT GAC AGG AGA TC-3′ (mutant reverse), 5′-CAA ATG TTG CTT GTC TGG TG-3′ (wild-type forward), 5′-GTC AGT CGA GTG CAC AGT TT-3′ (wild-type reverse). The primers for μMT genotyping as following: 5′-CCG TCT AGC TTG AGC TAT TAG G-3′ (common), 5′-GAA GAG GAC GAT GAA GGT GG-3′ (wild type), 5′-TTG TGC CCA GTC ATA GCC GAA T-3′ (mutant reverse). The primers for Cre genotyping are as following: 5′-GCG GTC TGG CAG TAA AAA CTA TC-3′ (transgene forward), 5′-GTG AAA CAG CAT TGC TGT CAC TT-3′ (transgene reverse), 5′-CTA GGC CAC AGA ATT GAA AGA TCT-3′ (internal positive control forward), 5′-GTA GGT GGA AAT TCT AGC ATC ATC C-3′ (internal positive control reverse). Littermate male mice were used in our experiments, and the identity was blinded for the investigator. Mice were housed under specific pathogen-free conditions in individually ventilated cages with wood shaving bedding in a climate-controlled environment having a 12-h light/dark cycle. We have mixed experimental cages of 6- to 8-week-old homozygous littermates. Each adult mouse weighed ~25 g. Experimental groups were randomized and distributed among mixed cages. The animal study protocols were approved by the Stockholm regional animal ethics committee, Sweden (N288/15).


The following antibodies were purchased from BioLegend, as CD45 (clone: 30-F11, APC or PE-Cyanine7), CD11b (clone: M1/70, Pacific Blue or APC), Ly6G (clone: 1A8, PerCP/Cy5.5), Ly6C (clone: HK1.4, APC or FITC), F4/80 (clone: BM8, PerCP/Cy5.5 or FITC), CD11c (clone: N418, APC or PE), and CD54 (clone: YN1/1.7.4, PE or FITC). Antibodies for CD16/CD32 (clone: 2.4G2, purified), Gr1 (clone: RB6-8C5, APC), CD115 (clone: T38-320, PE), CD3ε (clone: 145-2C11, FITC), NK1.1 (clone: PK136, Pacific Blue), CD27 (clone: LG.3A10, PerCP/Cy5.5), KLRG1 (clone: 2F1, APC), CD107a (clone: 1D4B, PE), and IFN-γ (clone: 1D4B, PE) were purchased from BD Biosciences. Antibodies for IL-1β (clone: NJTEN, FITC) were purchased from eBioscience. Antibodies for NCF1 (clone: D-10, FITC) were purchased from Santa Cruz Biotechnology. Antibodies for RAGE (clone: 697023) were purchased from R&D Systems. The usage of antibodies is according to the suggestions from the source companies, and the classical dilution ratio of the stock solution is 1:200 for flow cytometry staining.

Western blot

Bone marrow cells were flushed from one femur and one tibia per mouse with RPMI media (ThermoFisher, catalog no. 61870044) supplemented by 10% FBS. Red blood cells were lysed with ACK (Ammonium-Chloride-Potassium) buffer46. Neutrophils were magnetically isolated using anti-Ly6G antibody (Clone: 1A8, BioLegend) according to manufacturer’s instructions from Miltenyi Biotec. Purity was checked by Attune™ NxT Flow Cytometer. The cells were lysed with RIPA Buffer (Pierce, Thermo Scientific), and then subjected to electrophoresis and transferred to nitrocellulose membranes (ThermoFisher, catalog no. LC2001, Sweden). Membranes were incubated with antibodies for NCF1 (Clone: D-10, Santa Cruz Biotechnology) and cyclophilin A (ThermoFisher, catalog no. PA1-025, Sweden) at 1:1000 dilution, followed by incubation with HRP-conjugated goat anti-rabbit IgG (ThermoFisher, catalog no. 31460) at 1:20,000 dilution. The ChemiDoc XRS + Gel imaging system (Bio-Rad Laboratories AB, Sweden) was used for chemiluminescence detection.

Cytometric beads array

Cytokine levels in BALF were measured by flow cytometry using BD Cytometric Bead Array Mouse/Rat Soluble protein Master Buffer kit (IL-1α, IL-1β, IL-4, TNF-α, and IFN-γ), according to the manufacturer’s instruction (BD Biosciences, US).

Tumor transplantation

For studies of lung colonization, each mouse was intravenously injected with 1.5 × 105 B16F10 cells (ATCC CRL-6475) dissolved in 100 μL of phosphate-buffered saline (PBS, 1×; Life Technologies Europe BV, Sweden) on day 0. Mice were sacrificed to harvest lung tissues at the indicated time. Tumor colonies of B16F10 cells on the surface of lung lobes per mouse were counted under Leica M60 stereo zoom microscope (Leica, Micromedic AB, Sweden).

Administration of recombinant mouse IL-1β protein

Half an hour prior to the inoculation of tumor cells, the experimental mouse was administrated intraperitoneally with a single injection of 1 μg rmIL-1β protein (BioLegend, Catalog Number 575106, Sweden) dissolved in 200 μL of PBS. The controls were injected with 200 μL of PBS.

Ly6G ligation

Neutrophils were depleted by intraperitoneal injections of 250 μg anti-Ly6G antibody (BioXCell, Clone 1A8) every 3 days, and rat IgG2a isotype control (BioXCell, Clone 2A3) were used in the same way. The exact methods of injections were to inject at day −1, 2, 5, and 8 post-injection of B16F10 cells.

Administration of RAGE blocker FPS-ZM1

Mice were administrated intraperitoneally with 25 μg FPS-ZM1 (Merck, Catalog Number 553030, Sweden) dissolved in 200 μL of PBS per time. PBS was used as a control. Mice received FPS-ZM1 treatments on days −1, 0, 1, and 2 after intravenous injection of B16F10 cells.

Flow cytometry analysis

The single-cell suspension derived from blood and lung tissues was analyzed with flow cytometry. To prepare the single-cell suspensions, the lungs were dissected into smaller fragments and digested in PBS with 2 mg/mL collagenase type IV (Sigma, C5138, CAS no. 9001-12-1, Sweden), 100 U/mL DNase I (Roche, Sigma, Catalog Number 04716728001, Sweden), and 2 mM EDTA (Sigma, CAS no. 60-00-4, Sweden). The cell density was counted by using Sysmex KX-21N automated hematology analyzer (Sysmex Corporation, NY). The cell samples were stained with a LIVE/DEAD® fixable near-IR dead cell stain (ThermoFisher, catalog no. L10119, Sweden). After an anti-mouse CD16/CD32 Fc block, extracellular antigens were stained 20 min at 4 °C in PBS with 1% fetal bovine serum (FBS, Gibco, ThermoFisher, catalog no. 26140079, USA). To measure intracellular ROS, the staining of 3 μM DHR (ThermoFisher, Catalog Number D23806, Sweden) was conducted, respectively, after cell surface markers staining, followed by stimulation of 100 ng/mL of PMA (Sigma-Aldrich Co., CAS No. 16561-29-8, Sweden) for 30 min. To detect the intracellular expression of cytokines, the cells were stimulated with 100 ng/mL of PMA and 1 μg/mL of ionomycin in the presence of 5 μg/mL of brefeldin A (BFA) for 4 h at a humidified 37 °C, 5% CO2 incubator. The stock solutions of PMA, ionomycin (ThermoFisher, Catalog Number I24222, Sweden), and BFA (ThermoFisher, catalog no. B7450, Sweden) were prepared with dimethylsulfoxide (DMSO, Sigma-Aldrich Co., CAS no. 67-68-5, Sweden). For intracellular cytokine staining, cells were fixed and permeabilized using BD cytofix/cytoperm solution (BD Biosciences, catalog no. 554714, Sweden). Samples were acquired using BD LSR II flow cytometer. The workstation is managed by FACSDiva software version 8.0 (BD Biosciences), and the data were analyzed using the FlowJo software version 10.5.3 (TreeStar, Inc., OR).

Statistics and reproducibility

Statistical analyses were performed with Graph Prism software, version 8.2.1 (GraphPad Software, San Diego, USA). Unless otherwise stated, the Mann–Whitney U test was used to compare the means of two groups. All results are shown as mean ± standard error of the mean. P value < 0.05 was considered as significant: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.